Immunoregulation in human malaria: The challenge of understanding asymptomatic infection

Memorias do Instituto Oswaldo Cruz

Volumn 110, Issue 8, 2015, Pages 945-955

  de Mendonça, Vitor R ^a   Barral Netto, Manoel ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Asymptomatic infection; Biomarkers; Immune response; Networks

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; HAPTOGLOBIN; HEME OXYGENASE 1; INTERLEUKIN 10; PARASITE ANTIGEN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ASYMPTOMATIC INFECTION; DISEASE CARRIER; HETEROZYGOTE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; PARASITEMIA; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM;

ADAPTIVE IMMUNITY; ANTIGENS, PROTOZOAN; ASYMPTOMATIC INFECTIONS; BIOMARKERS; CARRIER STATE; DISEASE RESERVOIRS; FERRITINS; HAPTOGLOBINS; HEME OXYGENASE-1; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALARIA, FALCIPARUM; MALARIA, VIVAX; PARASITEMIA; PLASMODIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 84949641422     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760150241     Document Type: Article

References (144)

1. Abdel-Latif MS, Dietz K, Issifou S, Kremsner PG, Klinkert M-Q 2003. Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections. Infect Immun 71: 6229-6233.
2. Adegnika AA, Kremsner PG 2012. Epidemiology of malaria and helminth interaction: a review from 2001 to 2011. Curr Opin HIV AIDS 7: 221-224.
3. Alifrangis M, Lemnge MM, Moon R, Theisen M, Bygbjerg I, Ridley RG, Jakobsen PH 1999. IgG reactivities against recombinant rhoptry-associated protein-1 (rRAP-1) are associated with mixed Plasmodium infections and protection against disease in Tanzanian children. Parasitology 119: 337-342.
4. Allhorn M, Berggård T, Nordberg J, Olsson ML, Akerström B 2002. Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99: 1894-1901.
5. Alves FP, Gil LHS, Marrelli MT, Ribolla PEM, Camargo EP, da Silva LHP 2005. Asymptomatic carriers of Plasmodium spp as infection source for malaria vector mosquitoes in the Brazilian Amazon. J Med Entomol 42: 777-779.
6. Andrade BB, Araújo-Santos T, Luz NF, Khouri R, Bozza MT, Camargo LMA, Barral A, Borges VM, Barral-Netto M 2010a. Hemeimpairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J Immunol 185: 1196-1204.
7. Andrade BB, Barral-Netto M 2011. Biomarkers for susceptibility to infection and disease severity in human malaria. Mem Inst Oswaldo Cruz 106 (Suppl. I): 70-78.
8. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LMA, Barral A, Barral-Netto M 2010b. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 9: 13.
9. Andrade BB, Reis-Filho A, Souza-Neto SM, Raffaele-Netto I, Camargo LMA, Barral A, Barral-Netto M 2010c. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis 4: e650.
10. Andrade BB, Rocha BC, Reis-Filho A, Camargo LMA, Tadei WP, Moreira LA, Barral A, Barral-Netto M 2009. Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J 8: 121.
11. Andrade BB, Santos CJN, Camargo LM, Souza-Neto SM, Reis-Filho A, Clarêncio J, Mendonça VRR, Luz NF, Camargo EP, Barral A, Silva AAM, Barral-Netto M 2011. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One 6: e19841.
12. Anthony CN, Lau Y-L, Sum J-S, Fong M-Y, Ariffin H, Zaw W-L, Jeyajothi I, Mahmud R 2013. Malaysian child infected with Plasmodium vivax via blood transfusion: a case report. Malar J 12: 308.
13. Bachtiar LR, Unsworth CP, Newcomb RD 2013. Application of artificial neural networks on mosquito olfactory receptor neurons for an olfactory biosensor. Conf Proc IEEE Eng Med Biol Soc 2013: 5390-5393.
14. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM 1992. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267: 18148-18153.
15. Barbosa S, Gozze AB, Lima NF, Batista CL, Bastos M da S, Nicolete VC, Fontoura PS, Gonçalves RM, Viana SAS, Menezes MJ, Scopel KKG, Cavasini CE, Malafronte R dos S, da Silva-Nunes M, Vinetz JM, Castro MC, Ferreira MU 2014. Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural Amazonia. PLoS Negl Trop Dis 8: e3109.
16. Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AVS 2006. A Phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials 1: e29.
17. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, Soares MP 2003. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724-1726.
18. Billo MA, Johnson ES, Doumbia SO, Poudiougou B, Sagara I, Diawara SI, Diakité M, Diallo M, Doumbo OK, Tounkara A, Rice J, James MA, Krogstad DJ 2012. Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol 176 (Suppl.): S175-S185.
19. Bousema T, Okell L, Felger I, Drakeley C 2014. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 12: 833-840.
20. Braga EM, Barros RM, Reis TA, Fontes CJF, Morais CG, Martins MS, Krettli AU 2002. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon Region. Am J Trop Med Hyg 66: 461-466.
21. Brisebarre A, Kumulungui B, Sawadogo S, Atkinson A, Garnier S, Fumoux F, Rihet P 2014. A genome scan for Plasmodium falciparum malaria identifies quantitative trait loci on chromosomes 5q31, 6p21.3, 17p12, and 19p13. Malar J 13: 198.
22. Brouwer EE, van Hellemond JJ, van Genderen PJ, Slot E, van Lieshout L, Visser LG, Wismans PJ 2013. A case report of transfusion-transmitted Plasmodium malariae from an asymptomatic non-immune traveller. Malar J 12: 439.
23. Bunn HF, Jandl JH 1966. Exchange of heme among hemoglobin molecules. Proc Natl Acad Sci USA 56: 974-978.
24. Bunn HF, Jandl JH 1968. Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem 243: 465-475.
25. Cardoso MA, Ferreira MU, Camargo LM, Szarfarc SC 1994. Anaemia, iron deficiency and malaria in a rural community in Brazilian Amazon. Eur J Clin Nutr 48: 326-332.
26. Cattani JA, Gibson FD, Alpers MP, Crane GG 1987. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 81: 705-709.
27. Chimma P, Roussilhon C, Sratongno P, Ruangveerayuth R, Pattanapanyasat K, Pérignon J-L, Roberts DJ, Druilhe P 2009. A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria. PLoS Pathog 5: e1000631.
28. Clyde DF, Most H, McCarthy VC, Vanderberg JP 1973. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci 266: 169-177.
29. Cohen S, McGregor IA, Carrington S 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
30. Costa JDN, Zanchi FB, Rodrigues FLS, Honda ER, Katsuragawa TH, Pereira DB, Taborda RLM, Tada MS, Ferreira RGM, Pereirada-Silva LH 2013. Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax. Mem Inst Oswaldo Cruz 108: 98-105.
31. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P 2000. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275: 25122-25129.
32. da Cunha GB, Luitgards-Moura JF, Naves ELM, Andrade AO, Pereira AA, Milagre ST 2010. Use of an artificial neural network to predict the incidence of malaria in the city of Cantá, state of Roraima. Rev Soc Bras Med Trop 43: 567-570.
33. Dalko E, Das B, Herbert F, Fesel C, Pathak S, Tripathy R, Cazenave P-A, Ravindran B, Sharma S, Pied S 2015. Multifaceted roles of heme during severe Plasmodium falciparum infections in India. Infect Immun 83: 3793-3799.
34. Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, Rogier C, Mercereau-Puijalon O, Druilhe P 1996. Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg 54: 18-26.
35. Day KP, Marsh K 1991. Naturally acquired immunity to Plasmodium falciparum. Immunol Today 12: A68-71.
36. de Souza JB, Todd J, Krishegowda G, Gowda DC, Kwiatkowski D, Riley EM 2002. Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. Infect Immun 70: 5045-5051.
37. Depinay N, Franetich JF, Grüner AC, Mauduit M, Chavatte J-M, Luty AJF, van Gemert G-J, Sauerwein RW, Siksik J-M, Hannoun L, Mazier D, Snounou G, Rénia L 2011. Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS One 6: e17464.
38. Dolo H, Coulibaly YI, Dembele B, Konate S, Coulibaly SY, Doumbia SS, Diallo AA, Soumaoro L, Coulibaly ME, Diakite SAS, Guindo A, Fay MP, Metenou S, Nutman TB, Klion AD 2012. Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adults. PLoS Negl Trop Dis 6: e1890.
39. Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K 2005. B-cell memory to 3 Plasmodium falciparum blood-stage antigens in a malariaendemic area. J Infect Dis 191: 1623-1630.
40. Enevold A, Alifrangis M, Sanchez JJ, Carneiro I, Roper C, Børsting C, Lusingu J, Vestergaard LS, Lemnge MM, Morling N, Riley E, Drakeley CJ 2007. Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania. J Infect Dis 196: 451-459.
41. Facer CA, Brown J 1979. ABO blood groups and falciparum malaria. Trans R Soc Trop Med Hyg 73: 599-600.
42. Fasano M, Fanali G, Leboffe L, Ascenzi P 2007. Heme binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59: 436-440.
43. Felger I, Irion A, Steiger S, Beck HP 1999. Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania. Trans R Soc Trop Med Hyg 93 (Suppl 1): 3-9.
44. Ferreira A, Balla J, Jeney V, Balla G, Soares MP 2008. A central role for free heme in the pathogenesis of severe malaria: the missing link? J Mol Med (Berl) 86: 1097-1111.
45. Ferreira A, Marguti I, Bechmann I, Jeney V, Chora A, Palha NR, Rebelo S, Henri A, Beuzard Y, Soares MP 2011. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 145: 398-409.
46. Fesel C, Goulart LF, Silva Neto A, Coelho A, Fontes CJF, Braga EM, Vaz NM 2005. Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Malar J 4: 5.
47. Foo LC, Rekhraj V, Chiang GL, Mak JW 1992. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am J Trop Med Hyg 47: 271-275.
48. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF 2001. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 15: 899-906.
49. Friesen J, Silvie O, Putrianti ED, Hafalla JCR, Matuschewski K, Borrmann S 2010. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2: 40ra49.
50. Fugikaha E, Fornazari PA, Penhalbel R de SR, Lorenzetti A, Maroso RD, Amoras JT, Saraiva AS, Silva RU da, Bonini-Domingos CR, Mattos LC de, Rossit ARB, Cavasini CE, Machado RLD 2007. Molecular screening of Plasmodium sp. asymptomatic carriers among transfusion centers from Brazilian Amazon Region. Rev Inst Med Trop Sao Paulo 49: 1-4.
51. Gonçalves RM, Salmazi KC, Santos BAN, Bastos MS, Rocha SC, Boscardin SB, Silber AM, Kallás EG, Ferreira MU, Scopel KKG 2010. CD4+CD25+Foxp3+ regulatory T-cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun 78: 4763-4772.
52. Gonçalves RM, Scopel KKG, Bastos MS, Ferreira MU 2012. Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum? PLoS One 7: e44394.
53. Gouagna LC, Ferguson HM, Okech BA, Killeen GF, Kabiru EW, Beier JC, Githure JI, Yan G 2004. Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Western Kenya. Parasitology 128: 235-243.
54. Gozzelino R, Andrade BB, Larsen R, Luz NF, Vanoaica L, Seixas E, Coutinho A, Cardoso S, Rebelo S, Poli M, Barral-Netto M, Darshan D, Kühn LC, Soares MP 2012. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12: 693-704.
55. Gozzelino R, Jeney V, Soares MP 2010. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354.
56. Gozzelino R, Soares MP 2011. Heme sensitization to TNF-mediated programmed cell death. Adv Exp Med Biol 691: 211-219.
57. Hansson HH, Maretty L, Balle C, Goka BQ, Luzon E, Nkrumah FN, Schousboe ML, Rodrigues OP, Bygbjerg IC, Kurtzhals JAL, Alifrangis M, Hempel C 2015. Polymorphisms in the haem oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children. Malar J 14: 153.
58. Hebbel RP, Morgan WT, Eaton JW, Hedlund BE 1988. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA 85: 237-241.
59. Hoffman SL, Doolan DL 2000. Malaria vaccines-targeting infected hepatocytes. Nat Med 6: 1218-1219.
60. Jagannathan P, Eccles-James I, Bowen K, Nankya F, Auma A, Wam la S, Ebusu C, Muhindo MK, Arinaitwe E, Briggs J, Greenhouse B, Tappero JW, Kamya MR, Dorsey G, Feeney ME 2014. IFNγ/ IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog 10: e1003864.
61. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, SisayJoof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, SanJoaquin M, Achidi EA, Agbenyega T, Allen A, Amodu O, Corran P, Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe C V, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S, Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP 2009. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41: 657-665.
62. Jayavanth S, Singh M 2003. Artificial neural network analysis of malaria severity through aggregation and deformability parameters of erythrocytes. Clin Hemorheol Microcirc 29: 457-468.
63. Joos C, Marrama L, Polson HEJ, Corre S, Diatta A-M, Diouf B, Trape J-F, Tall A, Longacre S, Perraut R 2010. Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One 5: e9871.
64. Kapelski S, Klockenbring T, Fischer R, Barth S, Fendel R 2014. Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparum. J Leukoc Biol 96: 1131-1142.
65. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 89: 3200-3203.
66. Kho S, Marfurt J, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T 2015. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection. Infect Immun 83: 3224-3232.
67. Kiang R, Adimi F, Soika V, Nigro J, Singhasivanon P, Sirichaisinthop J, Leemingsawat S, Apiwathnasorn C, Looareesuwan S 2006. Meteorological, environmental remote sensing and neural network analysis of the epidemiology of malaria transmission in Thailand. Geospat Health 1: 71-84.
68. Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K 2004. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections. J Infect Dis 190: 1527-1533.
69. Koukouikila-Koussounda F, Ntoumi F, Ndounga M, Tong H V, Abena A-A, Velavan TP 2013. Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children. Malar J 12: 9.
70. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK 2001. Identification of the haemoglobin scavenger receptor. Nature 409: 198-201.
71. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, Pendame R, Taylor TE, Molyneux ME 2005. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 365: 233-240.
72. Kuesap J, Hirayama K, Kikuchi M, Ruangweerayut R, Na-Bangchang K 2010. Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity. Malar J 9: 260.
73. Kwiatkowski D 2000. Genetic susceptibility to malaria getting complex. Curr Opin Genet. Dev 10: 320-324.
74. Kwiatkowski D, Hill A V, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
75. Ladeia-Andrade S, Ferreira MU, Carvalho ME de, Curado I, Coura JR 2009. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Am J Trop Med Hyg 80: 452-459.
76. Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, Carlton JM, Joshi H 2012. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 11: 29.
77. Lemaitre M, Watier L, Briand V, Garcia A, Hesran JY Le, Cot M 2014. Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of schistosomiasis on malaria in Senegalese children. Am J Trop Med Hyg 90: 329-334.
78. Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L 2013. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther 11: 623-639.
79. Martin SK, Miller LH, Hicks CU, David-West A, Ugbode C, Deane M 1979. Frequency of blood group antigens in Nigerian children with falciparum malaria. Trans R Soc Trop. Med Hyg 73: 216-218.
80. Medzhitov R, Schneider DS, Soares MP 2012. Disease tolerance as a defense strategy. Science 335: 936-941.
81. Mendonça VR, Souza LC, Garcia GC, Magalhães BM, Lacerda MV, Andrade BB, Gonçalves MS, Barral-Netto M 2014. DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Malar J 13: 278.
82. Mendonça VRR de, Goncalves MS, Barral-Netto M 2012a. The host genetic diversity in malaria infection. J Trop Med 2012: 940616.
83. Mendonça VRR, Luz NF, Santos NJG, Borges VM, Gonçalves MS, Andrade BB, Barral-Netto M 2012b. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun 80: 1445-1454.
84. Mendonça VRR, Queiroz ATL, Lopes FM, Andrade BB, Barral-Netto M 2013. Networking the host immune response in Plasmodium vivax malaria. Malar J 12: 69.
85. Milet J, Nuel G, Watier L, Courtin D, Slaoui Y, Senghor P, Migot-Nabias F, Gaye O, Garcia A 2010. Genome wide linkage study, using a 250K SNP map, of Plasmodium falciparum infection and mild malaria attack in a Senegalese population. PLoS One 5: e11616.
86. Miller YI, Shaklai N 1999. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1454: 153-164.
87. Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey NM, Plebanski M 2009. Parasite-dependent expansion of TNF receptor II-positive regulatory T-cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog 5: e1000402.
88. Mombo L-E, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, Krisnamoorthy R 2003. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am J Trop Med Hyg 68: 186-190.
89. Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, Dent AE, John CC, Long CA, Vulule J, Kazura JW 2013. Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis 208: 149-158.
90. Mordmüller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, Grau GE, Kremsner PG 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 8: 29-35.
91. Najem GR, Sulzer AJ 2003. Transfusion-induced malaria from an asymptomatic carrier. Transfusion 16: 473-476.
92. Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, MercereauPuijalon O 1995. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am J Trop Med Hyg 52: 81-88.
93. Nussenzweig RS, Vanderberg J, Most H, Orton C 1967. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216: 160-162.
94. Olotu A, Moris P, Mwacharo J, Vekemans J, Kimani D, Janssens M, Kai O, Jongert E, Lievens M, Leach A, Villafana T, Savarese B, Marsh K, Cohen J, Bejon P 2011. Circumsporozoite-specific T-cell responses in children vaccinated with RTS,S/AS01E and protection against P. falciparum clinical malaria. PLoS One 6: e25786.
95. Ong’echa JM, Davenport GC, Vulule JM, Hittner JB, Perkins DJ 2011. Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods. Infect Immun 79: 4674-4680.
96. Oppenheimer SJ, Higgs DR, Weatherall DJ, Barker J, Spark RA 1984. Alpha thalassaemia in Papua New Guinea. Lancet 1: 424-426.
97. Overstreet MG, Cockburn IA, Chen Y-C, Zavala F 2008. Protective CD8 T-cells against Plasmodium liver stages: immunobiology of an “unnatural” immune response. Immunol Rev 225: 272-283.
98. Palm NW, Medzhitov R 2009. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 227: 221-233.
99. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM 2007. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13: 703-710.
100. Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A, Baker EN 1999. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat Struct Biol 6: 926-931.
101. Perdijk O, Arama C, Giusti P, Maiga B, Troye-Blomberg M, Dolo A, Doumbo O, Persson J-O, Boström S 2013. Haptoglobin phenotype prevalence and cytokine profiles during Plasmodium falciparum infection in Dogon and Fulani ethnic groups living in Mali. Malar J 12: 432.
102. Perkins DJ, Hittner JB, Mwaikambo ED, Granger DL, Weinberg JB, Anstey NM 2005. Impaired systemic production of prostaglandin E2 in children with cerebral malaria. J Infect Dis 191: 1548-1557.
103. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC 2004. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 94: 119-126.
104. Portugal S, Doumtabe D, Traore B, Miller LH, Troye-Blomberg M, Doumbo OK, Dolo A, Pierce SK, Crompton PD 2012. B-cell analysis of ethnic groups in Mali with differential susceptibility to malaria. Malar J 11: 162.
105. Portugal S, Tipton CM, Sohn H, Kone Y, Wang J, Li S, Skinner J, Virtaneva K, Sturdevant DE, Porcella SF, Doumbo OK, Doumbo S, Kayentao K, Ongoiba A, Traore B, Sanz I, Pierce SK, Crompton PD 2015. Malaria-associated atypical memory B-cells exhibit markedly reduced B-cell receptor signaling and effector function. Elife doi: 10.7554/eLife.07218.
106. Powrie F, Read S, Mottet C, Uhlig H, Maloy K 2003. Control of immune pathology by regulatory T-cells. Novartis Found Symp 252: 92-98, discussion 98-105, 106-114.
107. Quaye IK 2008. Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102: 735-742.
108. Rihet P, Traoré Y, Abel L, Aucan C, Traoré-Leroux T, Fumoux F 1998. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 63: 498-505.
109. Rodrigues M, Nussenzweig RS, Zavala F 1993. The relative contribution of antibodies, CD4+ and CD8+ T-cells to sporozoite-induced protection against malaria. Immunology 80: 1-5.
110. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJF, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, Mast Q de, Roeffen W, Snounou G, Rénia L, van der Ven A, Hermsen CC, Sauerwein R 2009. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468-477.
111. Roestenberg M, Teirlinck AC, McCall MBB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, van Gemert G, van der Vegte-Bolmer M, van der Ven AJAM, Luty AJF, Hermsen CC, Sauerwein RW 2011. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377: 1770-1776.
112. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F 1989. Cloned cytotoxic T-cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323-326.
113. Rono J, Osier FHA, Olsson D, Montgomery S, Mhoja L, Rooth I, Marsh K, Färnert A 2013. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Clin Infect Dis 57: 1409-1416.
114. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P 1991. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45: 297-308.
115. Sagna AB, Gaayeb L, Sarr JB, Senghor S, Poinsignon A, Boutouaba-Combe S, Schacht A-M, Hermann E, Faye N, Remoue F, Riveau G 2013. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal. Malar J 12: 301.
116. Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill A V, Bartholomay LC, Harty JT 2008. Memory CD8 T-cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA 105: 14017-14022.
117. Schneider P, Bousema JT, Gouagna LC, Otieno S, Vegte-Bolmer M van de, Omar SA, Sauerwein RW 2007. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg 76: 470-474.
118. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V 1987. Gamma interferon, CD8+ T-cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
119. Scuracchio P, Vieira SD, Dourado DA, Bueno LM, Colella R, RamosSanchez EM, Lima GFMC, Inoue J, Sanchez MCA, Santi SM Di 2011. Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae. Rev Inst Med Trop Sao Paulo 53: 55-59.
120. Shimizu H, Tamam M, Soemantri A, Ishida T 2005. Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia. J Hum Genet 50: 420-424.
121. Sikora M, Laayouni H, Menendez C, Mayor A, Bardaji A, Sigauque B, Netea MG, Casals F, Bertranpetit J 2011. A targeted association study of immunity genes and networks suggests novel associations with placental malaria infection. PLoS One 6: e24996.
122. Smith T, Felger I, Tanner M, Beck HP 1999. Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans R Soc Trop Med Hyg 93 (Suppl 1): 59-64.
123. Stephens R, Albano FR, Quin S, Pascal BJ, Harrison V, Stockinger B, Kioussis D, Weltzien H-U, Langhorne J 2005. Malaria-specific transgenic CD4(+) T-cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106: 1676-1684.
124. Stephens R, Langhorne J 2010. Effector memory Th1 CD4 T-cells are maintained in a mouse model of chronic malaria. PLoS Pathog 6: e1001208.
125. Tada MS, Ferreira RGM, Katsuragawa TH, Martha RCD, Costa JDAN, Albrecht L, Wunderlich G, da Silva LHP 2012. Asymptomatic infection with Plasmodium falciparum and Plasmodium vivax in the Brazilian Amazon Basin: to treat or not to treat? Mem Inst Oswaldo Cruz 107: 621-629.
126. Taylor SM, Cerami C, Fairhurst RM 2013. Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathog 9: e1003327.
127. Thornton AM, Shevach EM 2000. Suppressor effector function of CD4+CD25+ immunoregulatory T-cells is antigen nonspecific. J Immunol 164: 183-190.
128. Timmann C, Evans JA, König IR, Kleensang A, Rüschendorf F, Lenzen J, Sievertsen J, Becker C, Enuameh Y, Kwakye KO, Opoku E, Browne ENL, Ziegler A, Nürnberg P, Horstmann RD 2007. Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet 3: e48.
129. Timmann C, Thye T, Vens M, Evans J, May J, Ehmen C, Sievertsen J, Muntau B, Ruge G, Loag W, Ansong D, Antwi S, Asafo-Adjei E, Nguah SB, Kwakye KO, Akoto AOY, Sylverken J, Brendel M, Schuldt K, Loley C, Franke A, Meyer CG, Agbenyega T, Ziegler A, Horstmann RD 2012. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 489: 443-446.
130. Tolosano E, Fagoonee S, Morello N, Vinchi F, Fiorito V 2010. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal 12: 305-320.
131. Tran TM, Li S, Doumbo S, Doumtabe D, Huang C-Y, Dia S, Bathily A, Sangala J, Kone Y, Traore A, Niangaly M, Dara C, Kayentao K, Ongoiba A, Doumbo OK, Traore B, Crompton PD 2013. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 57: 40-47.
132. Tran TM, Samal B, Kirkness E, Crompton PD 2012. Systems immu nology of human malaria. Trends Parasitol 28: 248-257.
133. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P 1994. The Dielmo Project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
134. Tsuji M, Bergmann CC, Takita-Sonoda Y, Murata K, Rodrigues EG, Nussenzweig RS, Zavala F 1998. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol 72: 6907-6910.
135. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL 1999. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 4: 5-12.
136. Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S 2012. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malar J 11: 361.
137. Walther M, Caul A De, Aka P, Njie M, Amambua-Ngwa A, Walther B, Predazzi IM, Cunnington A, Deininger S, Takem EN, Ebonyi A, Weis S, Walton R, Rowland-Jones S, Sirugo G, Williams SM, Conway DJ 2012. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog 8: e1002579.
138. Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, Edele F, de Souza JB, Sinden RE, Gilbert SC, Riley EM, Hill AVS 2005. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T-cells correlates with more rapid parasite growth in human malaria infection. Immunity 23: 287-296.
139. Wammes LJ, Wiria AE, Toenhake CG, Hamid F, Liu KY, Suryani H, Kaisar MMM, Verweij JJ, Sartono E, Supali T, Smits HH, Luty AJ, Yazdanbakhsh M 2013. Asymptomatic plasmodial infection is associated with increased tumor necrosis factor receptor II-expressing regulatory T-cells and suppressed type 2 immune responses. J Infect Dis 207: 1590-1599.
140. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, Kayentao K, Ongoiba A, Doumbo OK, Pierce SK 2009. Atypical memory B-cells are greatly expanded in individuals living in a malariaendemic area. J Immunol 183: 2176-2182.
141. White NJ 2008. The role of anti-malarial drugs in eliminating malaria. Malar J 7 (Suppl 1): S8.
142. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, Omoding N, Okongo M, Malamba S, Ojwiya A 2000. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356: 1051-1056.
143. WHO World Health Organization 2014. World Malaria Report 2014. Available from: who.int/malaria/publications/world_malaria_report_2014/en/.
144. Wykes MN, Liu XQ, Beattie L, Stanisic DI, Stacey KJ, Smyth MJ, Thomas R, Good MF 2007. Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog 3: e96